AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced that updated clinical results from the Phase 1b TheraPb trial ...

Unless otherwise noted, all growth rates in this Release refer to same period in prior year. 2. Please see detailed guidance ...

The bill would permanently authorize and expand the Department of Veterans Affairs precision oncology program.

A noninvasive DNA blood test can identify patients with metastatic castration-resistant prostate cancer (mCRPC) who are most ...

A noninvasive DNA blood test can identify metastatic castration-resistant prostate cancer (mCRPC) patients who are most likely to benefit ...

A negative scan does not always mean recurrent prostate cancer is nowhere to be found. Sometimes, the disease may simply be ...

A noninvasive DNA blood test can identify metastatic castration-resistant prostate cancer (mCRPC) patients who are most ...

U.S. Defense Secretary Pete Hegseth says the screenings will boost the military’s readiness and resilience, but doctors ...

A retired Utah radiologist shares his experience with robotic surgery after a prostate cancer diagnosis and encourages other men to get screened.

In the biggest venture capital financing this week, clinical-stage radiopharmaceutical AdvanCell has closed a $315 million ...

A prostate cancer treatment used by Jeremy Clarkson is as effective as surgery or radiotherapy but has fewer side effects, a ...

Akeega prostate cancer UK approval: the MHRA has licensed Johnson and Johnson's niraparib-abiraterone combination for men ...